The cost of developing new pharmaceuticals has increased, while the number ofpharmaceuticals approved has declined. This highlights the importance for newpharmaceuticals to quickly become successful. The aim of this thesis is to explore thefactors of importance when launching new pharmaceuticals. Initially a literature reviewhas been conducted to explore general factors of importance for a pharmaceutical tobecome a commercial success. Furthermore, eleven in-depth interviews have beenperformed with stakeholders from the Swedish healthcare system to identify significantfactors on a national and regional level in Sweden. A thematic analysis was used tocategorize the data collected in the interviews. The result of the literature review showed that the value creating process is of utmostimportance for a pharmaceutical to become a success. This is affected by a customeroriented focus, the design of the pharmaceutical study and the outcome from the healtheconomic analysis. Additionally, a number of challenges in the pharmaceutical supplychain were identified, which could cause a bottleneck during the launch of newpharmaceuticals. In the empirical part a main theme ‘Trust’ with a total of seven subthemes was identified.The seven subthemes are factors that are essential to gain the trust and create the value,they are: ‘Guidelines and Regulations’, ‘Clinical Efficacy and Clinical Evidence’,‘Marketing’, ‘Information’, ‘Adherence and Compliance’, ‘Health Economics’ and‘Financial Aspect’. The subtheme ‘Guidelines and Regulations’ highlights the connectionbetween guidelines and utilization of pharmaceuticals. The ‘Clinical Efficacy and ClinicalEvidence’ was identified as the utmost important success factor. Furthermore the theme‘Value of Money’, including the subthemes ‘Health Economics’ and ‘Financial Aspect’,highlights the importance of the budget aspect and the increasing use of healtheconomics to evaluate health benefits and costs in healthcare. The subtheme ‘Adherenceand Compliance’ stresses the importance of information to the end user, whereas thesubtheme ‘Information’ highlights the information exchange among differentstakeholders. The subtheme ‘Marketing’ describes the effect of personal relationshipbetween industry and prescribers, and the effect on the pharmaceutical use it can have.
| Identifer | oai:union.ndltd.org:UPSALLA1/oai:DiVA.org:kth-190750 |
| Date | January 2016 |
| Creators | Falk, Emelie |
| Publisher | KTH, Skolan för bioteknologi (BIO) |
| Source Sets | DiVA Archive at Upsalla University |
| Language | Swedish |
| Detected Language | English |
| Type | Student thesis, info:eu-repo/semantics/bachelorThesis, text |
| Format | application/pdf |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0019 seconds